Zhang, N
Hashimoto's disease itself does not fall into these categories, but patients should be counselled about this theoretical risk
From our own study, more than 1 in 2 participants experienced better bowel movements after taking GLH-2
This stage often builds momentum, but staying consistent and following proper dosage is key
Patients should be counseled about symptoms of thyroid tumors, including a neck mass, dysphagia, dyspnea, or persistent hoarseness, though routine calcitonin monitoring is not recommended for surveillance in the absence of specific risk factors
c Negative other imaging modalities, consider [ 18 F]-fluoro-2-deoxy-D-glucose (F18-FDG) positron emission tomography-CT or Gallium-68 DOTATATE or CE MRI with neck, chest, abdomen with liver protocol in National Comprehensive Cancer Network (NCCN) guidelines